NEJM发布中国最新成果:洛匹那韦-利托那韦治疗Covid-19重症患者疗效不显著
Sohu News,
原标题: 近日,NEJM在线发表了中国最新研究成果《A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19》。这项随机对照试验评估了洛匹那韦-利托那韦(商品名:克力…
原标题: 近日,NEJM在线发表了中国最新研究成果《A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19》。这项随机对照试验评估了洛匹那韦-利托那韦(商品名:克力…
Some of the first clinical data for a potential coronavirus treatment showed it did not help patients with severe cases of COVID…
source REUTERS/Tobias Schwarz Some of the first clinical data for a potential coronavirus treatment showed it did not help…
REUTERS/Tobias Schwarz Some of the first clinical data for a potential coronavirus treatment showed it did not help patients…
REUTERS/Tobias Schwarz Some of the first clinical data for a potential coronavirus treatment showed it did not help patients…
Some of the first clinical data for a potential coronavirus treatment showed it did not help patients with severe cases of COVID…
Some of the first clinical data for a potential coronavirus treatment showed it did not help patients with severe cases of COVID…
Some of the first clinical data for a potential coronavirus treatment showed it did not help patients with severe cases of COVID…
For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website.
For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website.
For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website.